SCHEMBL6129779

SCHEMBL6129779

Cc1ccc(N=Nc2ccc3cccc(Nc4nc(Cl)nc(Nc5ccccc5)n4)c3c2O)cc1S(=O)(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FUT8 Q9BYC5 1/20 0.51
▸ NR4A1 P22736 1/20 0.44
▸ TTR P02766 1/20 0.43
▸ FABP4 P15090 1/20 0.43
▸ CCNA2 P20248 1/20 0.43
▸ CDK2 P24941 1/20 0.43
▸ MAPK14 Q16539 1/20 0.43
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ THRB P10828 1/20 0.41
▸ GLO1 Q04760 5/20 0.41
▸ CHAT P28329 3/20 0.38
▸ CA12 O43570 2/20 0.38
▸ CA1 P00915 2/20 0.38
▸ CA2 P00918 2/20 0.38
▸ CA9 Q16790 2/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ MAPT P10636 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ ENPP3 O14638 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7197090 0.81 FUT8 (0.72) FUT8MEN1KMT2ATHRBCHAT
SCHEMBL17190771 0.81 FUT8 (0.69) FUT8MEN1KMT2ATHRBCYP1A2
SCHEMBL9999814 0.80 FUT8 (0.60) FUT8NR4A1TTRFABP4CCNA2
SCHEMBL9999813 0.80 FUT8 (0.63) FUT8NR4A1TTRFABP4CCNA2
SCHEMBL25592390 0.79 FUT8 (0.54) FUT8MEN1KMT2ATHRBCHAT
SCHEMBL20390572 0.78 FUT8 (0.81) FUT8NR4A1MEN1KMT2ATHRB
SCHEMBL11995621 0.78 FUT8 (0.55) FUT8MEN1KMT2ACHATCA12
SCHEMBL19754268 0.77 FUT8 (0.69) FUT8MEN1KMT2ATHRBCYP1A2
SCHEMBL25592397 0.76 FUT8 (0.54) FUT8MEN1KMT2ATHRBCHAT
SCHEMBL12589955 0.75 FUT8 (0.67) FUT8MEN1KMT2ATHRBCHAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1161564-A4 SCREENING OF ANTIVIRAL COMPOUNDS TARGETED TO THE HIV-1 gp41 CORE STRUCTURE NEW YORK BLOOD CT INC (US) 2005-03-30 — — EP disclosed
EP-1161564-A1 SCREENING OF ANTIVIRAL COMPOUNDS TARGETED TO THE HIV-1 gp41 CORE STRUCTURE New York Blood Center, Inc. (US) 2001-12-12 — — EP disclosed
WO-2000055377-A1 SCREENING OF ANTIVIRAL COMPOUNDS TARGETED TO THE HIV-1 gp41 CORE STRUCTURE NEW YORK BLOOD CENTER, INC. (US) 2000-09-21 — — WO disclosed
Send feedback